Evidence map›Paper›PMID 41982389›Full record

ReviewEngineering microbiology2026

Advances in microbial mevalonolactone production: from fermentative mevalonate accumulation to downstream lactonization.

Hao Tang, Lihong Yin, Yiwen Jiang, Teng Xu, Ting Xue, Meimei Fu, Jianghao Chen, Jinshan Guo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Engineering microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hao TangSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Lihong YinHangzhou Ji Bei Technology Co., Ltd, Hangzhou 311121, China.
Yiwen JiangSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Teng XuSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Ting XueSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Meimei FuSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Jianghao ChenSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.
Jinshan GuoSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mevalonolactone (MVAL) is a high-value feedstock for the cosmetic industry, with (

Indexed as

BiosynthesisMetabolic engineeringMevalonate lactonizationMevalonolactoneMicrobial cell factories

Identifiers

PMID41982389
PMCPMC13064465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.